Innate Pharma SA (IPHA)
2.46
+0.06
(+2.50%)
USD |
NASDAQ |
Apr 26, 16:00
Innate Pharma Price: 2.46 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 26, 2024 | 2.44 | 2.46 | 2.41 | 2.46 | 6799.00 |
Apr 25, 2024 | 2.415 | 2.43 | 2.40 | 2.40 | 521.00 |
Apr 24, 2024 | 2.48 | 2.48 | 2.46 | 2.46 | 689.00 |
Apr 23, 2024 | 2.40 | 2.475 | 2.365 | 2.37 | 2674.00 |
Apr 22, 2024 | 2.35 | 2.48 | 2.32 | 2.425 | 9506.00 |
Apr 19, 2024 | 2.30 | 2.50 | 2.25 | 2.44 | 9449.00 |
Apr 18, 2024 | 2.35 | 2.38 | 2.32 | 2.35 | 10787.00 |
Apr 17, 2024 | 2.40 | 2.57 | 2.34 | 2.41 | 16301.00 |
Apr 16, 2024 | 2.34 | 2.59 | 2.34 | 2.59 | 6489.00 |
Apr 15, 2024 | 2.42 | 2.561 | 2.400 | 2.42 | 8062.00 |
Apr 12, 2024 | 2.52 | 2.59 | 2.48 | 2.48 | 12091.00 |
Apr 11, 2024 | 2.526 | 2.54 | 2.46 | 2.48 | 2988.00 |
Apr 10, 2024 | 2.50 | 2.53 | 2.37 | 2.52 | 14517.00 |
Apr 09, 2024 | 2.554 | 2.60 | 2.498 | 2.60 | 17698.00 |
Apr 08, 2024 | 2.38 | 3.15 | 2.38 | 2.60 | 54723.00 |
Apr 05, 2024 | 2.42 | 2.545 | 2.35 | 2.532 | 2623.00 |
Apr 04, 2024 | 2.43 | 2.510 | 2.405 | 2.50 | 4765.00 |
Apr 03, 2024 | 2.53 | 2.57 | 2.36 | 2.57 | 12598.00 |
Apr 02, 2024 | 2.52 | 2.71 | 2.422 | 2.52 | 19746.00 |
Apr 01, 2024 | 2.81 | 2.878 | 2.60 | 2.68 | 22981.00 |
Mar 28, 2024 | 2.378 | 2.90 | 2.378 | 2.88 | 57874.00 |
Mar 27, 2024 | 2.36 | 2.390 | 2.31 | 2.38 | 5207.00 |
Mar 26, 2024 | 2.40 | 2.44 | 2.36 | 2.44 | 1005.00 |
Mar 25, 2024 | 2.37 | 2.40 | 2.37 | 2.40 | 3298.00 |
Mar 22, 2024 | 2.36 | 2.385 | 2.36 | 2.372 | 1760.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.90
Minimum
Dec 16 2022
8.20
Maximum
May 11 2020
4.051
Average
3.45
Median
Jun 25 2021
Price Benchmarks
Sanofi SA | 49.13 |
DBV Technologies SA | 0.682 |
Cellectis SA | 2.506 |
PHAXIAM Therapeutics SA (DELISTED) | 3.10 |
Genfit SA | 3.49 |
Price Related Metrics
PS Ratio | 3.511 |
Price to Book Value | 3.466 |
Earnings Yield | -3.93% |
Market Cap | 198.87M |